• Heritage Action
  • More

Health Care

Health Providers and Industry

Obamacare's Comparative Effectiveness Research

One aspect of Obamacare is the promotion of “comparative effectiveness research.” Intended to compare treatment options, it can benefit patients only if used for informational purposes, and could also be harmful in practice. Read More.

Medicare Price Controls Contribute to Drug Shortages

Recent drug shortages have received national attention as patients are forced to wait for vital treatments or substitute an alternative. Read More.

Bad Medicine for Federal Workers and Taxpayers

President Barack Obama wants the Joint Committee on Deficit Reduction to kill market competition for prescription drug coverage chosen by workers and retirees in the Federal Employees Health Benefits Program. Read More.

The role of the federal and state governments is not to micro-manage health care providers, but to ensure that market competition takes place on a level playing field with reasonable rules and transparency so that consumers can make informed choices.


Experts on Health Providers and Industry